Home › Brain Diseases › Massachusetts
Brain Diseases clinical trials in Massachusetts
7 studies for Brain Diseases are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Massachusetts General Hospital - Charlestown, Charlestown
- K2 Medical Research - Foxborough, Foxborough
- Neurology Center of New England, Foxborough
- and 1 more
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 22, 2026 · NCT07589595Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Dana-Farber Cancer Institute, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Boston
- Clinical Site, Watertown
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Massachusetts General Hospital (MGH), Charlestown
RecruitingPhase 1
Ages 50 to 85 · All sexes · Updated Aug 24, 2026 · NCT06297590Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
- Massachusetts General Hospital, Boston
Recruiting
Ages 18 to 85 · All sexes · Updated May 14, 2026 · NCT05103566North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
- Massachusetts General Hospital, Boston
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 4, 2026 · NCT01694940Epilepsy Learning Healthcare System (ELHS)
- Partners - Massachusetts General Hospital Epilepsy Service (MGH)/ Partners - Brigham and Women's (BWH), Boston
- Brigham & Women's Hospital, Boston
RecruitingObservational study
All ages · All sexes · Updated Aug 30, 2024 · NCT06265103From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.